GlobeNewswire Inc | Oct 6, 2020 08:00AM EDT

October 06, 2020

BOSTON, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that it is investigating whether Applied Therapeutics, Inc. (NASDAQ: APLT) and Legend Biotech Corporation (NASDAQ: LEGN) may be liable for violations of the federal securities laws. If you purchased or acquired shares of Applied Therapeutics or Legend Biotech and have questions about your legal rights or possess information relevant to these investigations, please contact Block & Leviton attorneys at (617) 398-5600, via email at cases@blockleviton.com, or via the following links:

Applied Therapeutics Shareholders Click Here: https://www.blockleviton.com/cases/aplt

Legend Biotech Shareholders Click Here: https://www.blockleviton.com/cases/legend

Applied Therapeutics, Inc. (NASDAQ: APLT)

On August 17, 2020, Applied Therapeutics disclosed that the U.S. Food and Drug Administration had placed a partial clinical hold on the Companys ACTION-Kids study, evaluating the Companys AT-007 product for the treatment of galactosemia. The FDA cited the need for additional technical information relating to ensuring that each study participant has access to the drugs benefits. On this news, shares of Applied Therapeutics stock fell $3.53 per share, or 12.07%, to close at $25.71, and the stock has declined further since.

Legend Biotech Corp. (NASDAQ: LEGN)

Before the markets opened on September 21, 2020, Legend Biotech announced that its Chief Executive Officer, Dr. Fangliang Zhang, had been placed under residential surveillance by Chinese law enforcement authorities. In addition, Legend Biotech announced that the Chinese Customs Anti-Smuggling Department has inspected places of business in Nanjing and Zhenjiang, China, of GenScript Biotech Corporation, Legend Biotechs parent and majority shareholder. These inspections, which included Legend Biotechs location in Nanjiang, are related to an investigation concerning suspected violations of import and export regulations under Chinese law. On this news, shares of Legend Biotech plummeted.

If you purchased or acquired shares of Applied Therapeutics or Legend Biotech and have questions about your legal rights or possess information relevant to these investigations, please contact Block & Leviton attorneys at (617) 398-5600, via email at cases@blockleviton.com, or using the links provided above.

Block & Leviton LLP is a firm dedicated to representing investors and maintaining the integrity of the countrys financial markets. The firm represents many of the nations largest institutional investors as well as individual investors in securities litigation throughout the United States. The firms lawyers have recovered billions of dollars for its clients.

This notice may constitute attorney advertising.

CONTACT:BLOCK & LEVITON LLP260 Franklin St., Suite 1860Boston, MA 02110Phone: (617) 398-5600Email: cases@blockleviton.comSOURCE: Block & Leviton LLPwww.blockleviton.com